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SORBITOL-MODIFIED HYALURONIC ACID REDUCES OXIDATIVE
STRESS, APOPTOSIS AND MEDIATORS OF INFLAMMATION AND
CATABOLISM IN HUMAN OSTEOARTHRITIC CHONDROCYTES
J.-M. Mongkhon, M. Thach, Q. Shi, J.C. Fernandes, H. Fahmi,
M. Benderdour. Univ. of Montreal, Montreal, QC, Canada
Purpose: We design a study to elucidate the precise molecular mech-
anisms by which Sorbitol-modiﬁed hyaluronic acid (sorbitol/HA) exerts
beneﬁcial effects in osteoarthritis (OA).
Methods: Human OA chondrocytes were treated with increasing doses
of sorbitol/HA and thereafter with or without interleukin-1beta (IL-1b)
or hydrogen peroxide (H2O2). Signal transduction pathways and
parameters related to oxidative stress, apoptosis, inﬂammation, and
catabolism were investigated.
Results: Sorbitol/HA prevented IL-1 b-induced oxidative stress, as
measured by reactive oxygen species (ROS), p47-NADPH oxidase (p47-
NOX) phosphorylation, 4-hydroxynonenal (HNE) production and HNE-
metabolizing glutathione-s-transferase A4-4 (Gsta4-4) expression.
Moreover, sorbitol/HA stiﬂed IL-1b-induced metalloproteinase 13
(MMP-13), nitric oxide (NO) and prostaglandin E2 (PGE2) release as well
as inducible NO synthase expression. Investigation of the apoptosis
process revealed that this gel signiﬁcantly attenuated cell death, cas-
pase-3 activation and DNA fragmentation elicited by exposure to a
cytotoxic H2O2 dose. Examination of signalling pathway components
revealed that sorbitol/HA prevented IL-1b-induced p38 mitogen-acti-
vated protein kinase and nuclear factor-kappa B activation, but not that
of extracellular signal-regulated kinases 1 and 2.
Conclusions: Altogether, our ﬁndings support a beneﬁcial effect of
sorbitol/HA in OA through restoring redox status and reducing markers
of apoptosis, inﬂammation and catabolism involved in cartilage dam-
age.
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LOCAL RAS AND ROS IN THE HYPERTROPHIC DIFFERENTIATION OF
CHONDROCYTES
I. Tsukamoto y, F. Nakamura y, S. Inoue y, T. Teramura z, T. Takehara z,
Y. Onodera z, M. Akagi y. yDept. of Orthopaedic Surgery, Faculty of Med.,
Kinki Univ., Osaka-Sayama City, Japan; zDiv. of Cell Biology for
Regenerative Med., Inst. of Advanced Clinical Med., Kinki Univ., Osaka-
Sayama City, Japan
Purpose: In 2013, we reported that the local renin-angiotensin system
(RAS) can modulate the hypertrophic differentiation of chondrocytes
activating angiotensin II type 1 receptor (AT1R) or angiotensin II type 2
receptor (AT2R). However, the details of the modulation have not been
revealed. On the other hand, many researchers have already reported
that the local RAS can modulate hypertrophic changes modulating the
generations of reactive oxygen species (ROS) in vascular endothelial
cells. The purpose of our study is to reveal whether or not the local RAS
modulates the hypertrophic differentiation of chondrocytes modulating
the generations of ROS.
Methods: We cultured ATDC5 cell line under the inducing of 10 mg/ml
bovine insulin for 14 days after they had reached conﬂuence. Then, we
added 1.0 mg/ml angiotensin II, 1.0 mg/ml Olmesartan and 1.0 mg/ml
PD123319 to activate AT1R or AT2R separately. 6 times after the acti-
vation of the receptors, we measured the concentrations of ROS. We
also administered vitamin C, vitamin E and hyaluronic acid (HA) and
measured the concentrations of ROS and the expressions of type X
collagen (Col.X), matrix metalloproteinase 13 (MMP13) and runt-rela-
ted transcription factor (Runx2).
Results: The generations of ROS were downregulated activating AT1R
and were conversely upregulated activating AT2R. In the upregulated
hypertrophic differentiation caused by activating AT2R, the expressions
of Col.x, MMP13 and Runx2 and the generations of ROS were down-
regulated administering vitamin C, vitamin E and HA. However, in the
downregulated hypertrophic differentiation caused by activating AT1R,
we did not ﬁnd signiﬁcant changes in the the expressions of Col.x,
MMP13 and Runx2 and the generations of ROS administering vitamin C,
vitamin E and HA .
Conclusions: The local RAS could modulate the hypertrophic differ-
entiation of chondrocytes modulating the generations of ROS. Upre-
gulation of hypertrophic differentiation of chondrocytes cased by
activating AT2R could be suppressed by administering vitamin C, vita-
min E and HA.240
PANNEXIN 3: A NEW CHANNEL INTO THE MECHANISMS OF
OSTEOARTHRITIS
P. Moon, S. Penuela, D.W. Laird, F. Beier. Western Univ., London, ON,
Canada
Purpose: With the increasing burden of osteoarthritis (OA), there is a
tremendous need to understand the molecular pathways driving car-
tilage catabolism in OA. Because these mechanisms are incompletely
understood, we have no effective interventions to slow or halt disease
progression, therefore limiting our ability to treat patients to symp-
tomatic management and ultimately joint replacement. Ectopic
hypertrophic differentiation of articular chondrocytes has been
observed during various stages of the disease, and is an important
pathway causing cartilage loss and cell death. During endochondral
ossiﬁcation, increasing cell size, catabolic gene expression, reductions
in type II collagen and aggrecan and ultimately apoptosis lead to car-
tilage resorption in order make way for new bone, and some of these
processes are recapitulated to various degrees in OA. One possible key
factor in this process is Pannexin 3(Panx3), an ATP releasing channel
forming glycoprotein that we have shown to be upregulated 5-fold in
OA cartilage (rat) and in the hypertrophic zone of the growth plate.
Overexpression of Panx3 in ATDC5 cells leads to accelerated differ-
entiation while knockdown leads to delayed differentiation (Iwamoto
et al 2010). Therefore we hypothesize that Panx3 is an important
driver of chondrocyte hypertrophy and will investigate its role further
using mice deﬁcient for Panx3 both globally and speciﬁcally in the
cartilage.
Methods: Using the Cre-LoxP system we have generated mice with
global deletion of Panx3 (CMV-cre) and with cartilage speciﬁc deletion
(Col2Cre). Development of OA is assessed after surgically inducing OA.
Surgical destabilization of the medial meniscus (DMM) has been shown
to produce reliable OA like pathologies and this technique has been
performed on both mutant and control mice aged 20 weeks. 8 weeks
post-surgery, these mice are compared to assess the severity of OA
using the OARSI histopathological scoring system and immunohis-
tochemistry for markers of OA and hypertrophy (MMP13, ColX, matrix
breakdown products). Serum biomarkers of matrix breakdown will be
detected using ELISA. Additionally, to determine whether activity levels
change in parallel to OA severity, spontaneous activity is measured.
In parallel to our in vivo studies, using primary articular chondrocytes
isolated from both mutant and control mice, we further investigate
molecular pathways affected by Panx3. By stimulating these cells with
pro-inﬂammatory or pro-hypertrophic factors (IL-1b, IL8, TNFa) we can
measure differential responses using qPCR and western blot to identify
changes in the expression of OA-relevant genes and markers of hyper-
trophy while also measuring ATP release.
Results: Mice with whole body deletion of Panx3 develop normally,
with no growth-plate, joint or skeletal abnormalities, making them
suitable models to study OA progression. In control mice that have
undergone DMM surgery, we see strong increases in Panx3 protein
staining as detected by IHC, localized primarily around lesions con-
sistent with early cartilage degeneration. We expect to see that the loss
of Panx3, both in cartilage, and in the whole animal will lead to reduced
OA development following surgery in addition to reduced catabolic and
hypertrophic markers. We also expect that primary chondrocytes from
Panx3 deﬁcient mice will be less responsive to pro-inﬂammatory and
pro-hypertrophic stimuli, and that ATP release will also be impaired
compared to controls.
Conclusion: Our in vivo study will identify whether Panx3 plays a role
in OA progression using outcome measures ranging from histology to
functional deﬁciency’s while our in vitro studies will provide insight
into some of the downstream mechanisms responsible. This will
explore a novel target for the development of OA therapy.Cartilage Repair
241
M2-MACROPHAGES MODULATE THE CARTILAGE-FORMING
CAPACITY OF HUMAN BONE MARROW-DERIVED MESENCHYMAL
STEM/PROGENITOR CELL
S.B. Sesia y, R. Duhr z, C. Medeiros da Cunha z, F. Wolf z, E. Padovan z,
G.C. Spagnoli z, I. Martin z, A. Barbero z. yUniv. Children’s Hosp. of Basle,
Basle, Switzerland; zDept. of Biomedicine, Univ. Hosp. of Basle, Basle,
Switzerland
